RUNX3 negatively regulates CD36 expression in myeloid cell lines

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• CD36 is a scavenger receptor involved in lipoprotein binding, fatty acid uptake, and apoptotic cell recognition by mononuclear phagocytes.
• CD36 plays a role in preventing autoimmunity by impairing dendritic cell (DC) maturation and acts as a coreceptor for TLR2/6 in sensing microbial diacylglycerides.
• RUNX3 transcription factor is crucial for DC reprogramming and its deficiency leads to accelerated DC maturation.

Purpose of the Study:

• To investigate the regulatory relationship between RUNX3 transcription factor and CD36 expression in myeloid cells.
• To elucidate the molecular mechanisms by which RUNX3 influences CD36 gene regulation.
• To understand the implications of RUNX3-mediated CD36 down-regulation on immune cell function and autoimmune responses.

Main Methods:

• In vitro assays to assess RUNX3 binding to the CD36 gene regulatory region.
• In vivo studies to confirm RUNX3 occupancy of the CD36 gene locus.
• Overexpression of RUNX3 in myeloid cells to evaluate its effect on CD36 expression levels.

Main Results:

• RUNX3 transcription factor negatively regulates CD36 expression during myeloid cell differentiation and activation.
• RUNX3 directly impairs the proximal regulatory region of the CD36 gene by recognizing specific binding elements.
• RUNX3 occupies the CD36 gene regulatory region in vivo, and its overexpression significantly reduces CD36 expression.

Conclusions:

• RUNX3 acts as a negative regulator of CD36 expression in myeloid cells.
• RUNX3-mediated down-regulation of CD36 may impair the recognition of pathogens and apoptotic cells by mature DCs.
• This regulatory mechanism suggests a role for RUNX3 in mitigating autoimmune responses by modulating DC function.